These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1164059)

  • 21. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surgical treatment and regional chemotherapy in melanoma of the extremities].
    Henneking K; Binder J; Weyers W; Schwemmle K
    Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical results of extremity perfusion in malignant melanoma].
    Huber R; Stützer H; Krüger I
    Zentralbl Chir; 1996; 121(3):234-42. PubMed ID: 8867351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perfusion therapy for extremity melanoma.
    Brown AS; Wallack MK; Horstmann JT; Hamilton RW; Johnson JL; Rosato FE
    Arch Surg; 1976 Sep; 111(9):961-3. PubMed ID: 949257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomy.
    Fletcher JR; White CR; Fletcher WS
    Am J Surg; 1986 May; 151(5):593-8. PubMed ID: 3518512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion.
    Schraffordt Koops H; Beekhuis H; Oldhoff J; Oosterhuis JW; van der Ploeg E; Vermey A
    Cancer; 1981 Nov; 48(9):1952-7. PubMed ID: 7296506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated regional perfusion in the treatment of malignant melanomas of the extremities.
    Schraffordt Koops H; Oldhoff J; van der Ploeg E; Vermey A; Eibergen R
    Arch Chir Neerl; 1975; 27(4):237-43. PubMed ID: 1211947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.
    Schraffordt Koops H; Kroon BB; Oldhoff J; Hoekstra HJ
    World J Surg; 1992; 16(2):241-5. PubMed ID: 1561805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous melanoma: a twenty-year retrospective study with clinicopathologic correlation.
    Franklin JD; Reynolds VH; Page DL
    Plast Reconstr Surg; 1975 Sep; 56(3):277-85. PubMed ID: 1153544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases.
    Deroose JP; Grünhagen DJ; Eggermont AM; Verhoef C
    Melanoma Res; 2015 Oct; 25(5):427-31. PubMed ID: 26110555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated limb perfusion for stage I melanoma of the extremity: a comparison of melphalan and dacarbazine (DTIC).
    Edwards MJ; Boddie AW; Ames FC; McBride CM
    South Med J; 1989 Aug; 82(8):985-7, 989. PubMed ID: 2762904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of regional perfusion treatment on recurrent melanoma of the extremities.
    Hansson JA; Simert G; Vang J
    Acta Chir Scand; 1977; 143(1):33-9. PubMed ID: 855620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Various aspects of treatment of primary melanoblastoma of the extremities by regional perfusion].
    Schraffordt Koops H; Eibergen R; Oldhoff J; van der Ploegen E; Vermey A
    Ned Tijdschr Geneeskd; 1975 Nov; 119(45):1746-53. PubMed ID: 1214883
    [No Abstract]   [Full Text] [Related]  

  • 34. Melanoma-in-transit presenting as panniculitis.
    Cotton J; Armstrong DJ; Wedig R; Hood AF
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):876-8. PubMed ID: 9810920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperthermic isolation-perfusion with melphalan, a preliminary appraisal of local and general effects in malignant melanoma.
    Lejeune FJ; Mathieu M; Kenis Y
    Tumori; 1977; 63(3):289-98. PubMed ID: 898296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.
    Sutherland CM; Mather FJ; Krementz ET
    Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To perfuse or not to perfuse? A retrospective comparative study to evaluate the effect of adjuvant isolated regional perfusion in patients with stage I extremity melanoma with a thickness of 1.5 mm or greater.
    Franklin HR; Schraffordt Koops H; Oldhoff J; Czarnetzki BM; Macher E; Kroon BB; Welvaart K; van der Velden JW; van Dijk E; van der Esch EP
    J Clin Oncol; 1988 Apr; 6(4):701-8. PubMed ID: 3357008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
    White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.